Press Releases Alembic Limited

Equities

ALEMBICLTD

INE426A01027

Market Closed - Bombay S.E. Other stock markets 06:00:51 2024-06-12 am EDT			5-day change	1st Jan Change
104.2 ^INR	+1.31%		+14.32%	+15.01%

May. 30	Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets	MT
May. 13	Alembic Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alembic Pharmaceuticals - Revenue up 18% to Rs. 1486 crores in Q-1 FY24	23-08-07	AQ
Alembic : Annual Report 2022-23	23-07-12	PU
Alembic : AL-Extract-Consolidated Financial Result-IE-Eng-12.05.2023	23-05-11	PU
Alembic : AL-Extract-Consolidated Financial Result-FE-Guj-12.05.2023	23-05-11	PU
Alembic : Audited Financial Results for the Quarter and Financial year ended 31st March, 2023	23-05-11	PU
Alembic Pharmaceuticals receives USFDA Final Approval for Cyclophosphamide Capsules 25 mg and 50 mg	22-11-14	AQ
Alembic Pharmaceuticals announces its first injectable product approval from its General Sterile Facility Final Approval for Glycopyrrolate Injection USP	22-11-02	AQ
Alembic Pharmaceuticals receives USFDA Final Approval for Paclitaxel Injection USP, 30 mg/5 mL, 100 mg/16.7 mL, and 300 mg/50 mL Multiple-Dose Vials.	22-10-28	AQ
Alembic : Spurt in Volume	22-10-03	PU
TTAB Trifusal: ALEMBIC PHARMACEUTICALS Refusals Affirmed - Likelihood Of Confusion, Failure-to-Function, And Nonuse	22-09-16	AQ
Alembic Pharmaceuticals receives USFDA Final Approval for Chlorthalidone Tablets USP, 25 mg and 50 mg.	22-08-30	AQ
Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%	22-08-09	AQ
Alembic reports revenue for Q1 FY23 Rs. 1262 Cr.	22-08-05	AQ
Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Diclofenac Sodium Topical Gel, 3%	22-08-01	AQ
Alembic Pharmaceuticals receives USFDA Final Approval for Pirfenidone Tablets, 267 mg a~d 801 mg	22-05-25	AQ
Alembic Pharmaceuticals announces USFDA Tentative Approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg	22-04-08	AQ
Alembic : Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Metronidazole Gel USP. 1%	21-09-07	AQ
Alembic : Pharmaceuticals announces USFOA Final Approval for Erlotinib Tablets, 25 mg, 100 mg, and 150 mg.	21-07-12	AQ
Alembic : Pharmaceuticals announces USFDA Final Approval for Desipramine Hydrochloride Tablets USP, 10 mg. 25 mg. 50 mg, 75 mg, 100 mg, and 150 mg	21-07-09	AQ
Alembic : Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Metronidazole Gel USP, 1%.	21-05-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Alembic Limited

Equities

ALEMBICLTD

INE426A01027

Press Releases

Filters